IceCure Medical Ltd. (ICCM)
NASDAQ: ICCM · IEX Real-Time Price · USD
1.90
-0.01 (-0.52%)
May 20, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 4.14 | 3.87 | 1.63 |
| Revenue Growth (YoY) | 6.98% | 137.74% | - |
| Cost of Revenue | 1.94 | 1.42 | 1.1 |
| Gross Profit | 2.2 | 2.44 | 0.52 |
| Selling, General & Admin | 6.04 | 2.78 | 2.31 |
| Research & Development | 5.88 | 3.81 | 3 |
| Operating Expenses | 11.92 | 6.59 | 5.31 |
| Operating Income | -9.72 | -4.14 | -4.78 |
| Interest Expense / Income | 0.17 | -0.41 | 0 |
| Other Expense / Income | 0 | 0 | -0.23 |
| Pretax Income | -9.9 | -3.73 | -4.55 |
| Net Income | -9.9 | -3.73 | -4.55 |
| Net Income Common | -9.9 | -3.73 | -4.55 |
| Shares Outstanding (Basic) | 29 | 17 | 14 |
| Shares Outstanding (Diluted) | 29 | 17 | 14 |
| Shares Change | 66.67% | 25.75% | - |
| EPS (Basic) | -0.35 | -0.22 | -0.33 |
| EPS (Diluted) | -0.35 | -0.22 | -0.33 |
| Free Cash Flow Per Share | -0.46 | -0.23 | -0.15 |
| Gross Margin | 53.04% | 63.19% | 32.21% |
| Operating Margin | -234.99% | -107.08% | -294.04% |
| Profit Margin | -239.13% | -96.43% | -279.72% |
| Free Cash Flow Margin | -317.50% | -101.16% | -128.58% |
| EBITDA | -9.6 | -4.08 | -4.52 |
| EBITDA Margin | -231.92% | -105.46% | -277.75% |
| EBIT | -9.72 | -4.14 | -4.55 |
| EBIT Margin | -234.99% | -107.08% | -279.72% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).